Data progression.

Did CURB leave you itching to know how all sorts of primary cancers fare with ablative radiation for oligoprogressive disease? This Korean retrospective review of 4157 patients treated at a single institution with standard chemo for metastatic colorectal cancer reports that those receiving radiation to five or fewer oligoprogressive/persistent sites of disease (n=91) achieved almost double the median time to systemic therapy change (9.5 months) than those who didn’t (5 months). | Lee, Clin Colorectal 2021


Popular Posts